vs

Side-by-side financial comparison of Cryoport, Inc. (CYRX) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.

Cryoport, Inc. is the larger business by last-quarter revenue ($45.5M vs $41.3M, roughly 1.1× Northfield Bancorp, Inc.). Cryoport, Inc. runs the higher net margin — -17.5% vs -1545.5%, a 1528.0% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs 9.6%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-4.5M). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs 10.4%).

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

CYRX vs NFBK — Head-to-Head

Bigger by revenue
CYRX
CYRX
1.1× larger
CYRX
$45.5M
$41.3M
NFBK
Growing faster (revenue YoY)
NFBK
NFBK
+3.0% gap
NFBK
12.7%
9.6%
CYRX
Higher net margin
CYRX
CYRX
1528.0% more per $
CYRX
-17.5%
-1545.5%
NFBK
More free cash flow
NFBK
NFBK
$57.1M more FCF
NFBK
$52.5M
$-4.5M
CYRX
Faster 2-yr revenue CAGR
NFBK
NFBK
Annualised
NFBK
15.0%
10.4%
CYRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYRX
CYRX
NFBK
NFBK
Revenue
$45.5M
$41.3M
Net Profit
$-8.0M
$-27.4M
Gross Margin
47.8%
Operating Margin
-17.0%
-1263.3%
Net Margin
-17.5%
-1545.5%
Revenue YoY
9.6%
12.7%
Net Profit YoY
57.4%
-343.6%
EPS (diluted)
$-0.19
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYRX
CYRX
NFBK
NFBK
Q4 25
$45.5M
$41.3M
Q3 25
$44.2M
$39.2M
Q2 25
$45.5M
$38.9M
Q1 25
$41.0M
$34.8M
Q4 24
$41.5M
$36.7M
Q3 24
$38.3M
$31.8M
Q2 24
$39.7M
$31.5M
Q1 24
$37.3M
$31.3M
Net Profit
CYRX
CYRX
NFBK
NFBK
Q4 25
$-8.0M
$-27.4M
Q3 25
$-6.9M
$10.8M
Q2 25
$105.2M
$9.6M
Q1 25
$-12.0M
$7.9M
Q4 24
$-18.7M
$11.3M
Q3 24
$805.0K
$6.5M
Q2 24
$-78.0M
$6.0M
Q1 24
$-18.9M
$6.2M
Gross Margin
CYRX
CYRX
NFBK
NFBK
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Q1 24
40.4%
Operating Margin
CYRX
CYRX
NFBK
NFBK
Q4 25
-17.0%
-1263.3%
Q3 25
-22.5%
37.7%
Q2 25
-21.2%
35.6%
Q1 25
-23.1%
31.0%
Q4 24
-30.7%
38.0%
Q3 24
-34.9%
27.9%
Q2 24
-196.5%
29.1%
Q1 24
-46.9%
27.2%
Net Margin
CYRX
CYRX
NFBK
NFBK
Q4 25
-17.5%
-1545.5%
Q3 25
-15.7%
27.4%
Q2 25
231.4%
24.6%
Q1 25
-29.2%
22.6%
Q4 24
-45.1%
30.7%
Q3 24
2.1%
20.5%
Q2 24
-196.4%
18.9%
Q1 24
-50.7%
19.9%
EPS (diluted)
CYRX
CYRX
NFBK
NFBK
Q4 25
$-0.19
$-0.68
Q3 25
$-0.18
$0.27
Q2 25
$2.05
$0.24
Q1 25
$-0.28
$0.19
Q4 24
$-0.42
$0.27
Q3 24
$-0.02
$0.16
Q2 24
$-1.62
$0.14
Q1 24
$-0.43
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYRX
CYRX
NFBK
NFBK
Cash + ST InvestmentsLiquidity on hand
$411.2M
$164.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$502.6M
$690.1M
Total Assets
$765.0M
$5.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYRX
CYRX
NFBK
NFBK
Q4 25
$411.2M
$164.0M
Q3 25
$421.3M
$131.7M
Q2 25
$426.0M
$97.6M
Q1 25
$244.0M
$101.7M
Q4 24
$250.6M
$167.7M
Q3 24
$259.4M
$232.9M
Q2 24
$414.9M
$153.5M
Q1 24
$438.2M
$238.8M
Total Debt
CYRX
CYRX
NFBK
NFBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$666.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CYRX
CYRX
NFBK
NFBK
Q4 25
$502.6M
$690.1M
Q3 25
$513.3M
$719.6M
Q2 25
$519.1M
$710.3M
Q1 25
$398.8M
$711.1M
Q4 24
$401.9M
$704.7M
Q3 24
$418.6M
$699.6M
Q2 24
$400.1M
$693.0M
Q1 24
$472.2M
$698.4M
Total Assets
CYRX
CYRX
NFBK
NFBK
Q4 25
$765.0M
$5.8B
Q3 25
$774.3M
$5.7B
Q2 25
$773.9M
$5.7B
Q1 25
$699.8M
$5.7B
Q4 24
$703.5M
$5.7B
Q3 24
$701.8M
$5.7B
Q2 24
$852.3M
$5.7B
Q1 24
$942.8M
$5.9B
Debt / Equity
CYRX
CYRX
NFBK
NFBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.95×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYRX
CYRX
NFBK
NFBK
Operating Cash FlowLast quarter
$919.0K
$53.7M
Free Cash FlowOCF − Capex
$-4.5M
$52.5M
FCF MarginFCF / Revenue
-10.0%
127.1%
Capex IntensityCapex / Revenue
12.0%
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.0M
$89.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYRX
CYRX
NFBK
NFBK
Q4 25
$919.0K
$53.7M
Q3 25
$2.2M
$13.9M
Q2 25
$-7.3M
$14.1M
Q1 25
$-4.3M
$9.4M
Q4 24
$-5.5M
$31.1M
Q3 24
$447.0K
$14.0M
Q2 24
$-8.0M
$6.9M
Q1 24
$-3.3M
$4.2M
Free Cash Flow
CYRX
CYRX
NFBK
NFBK
Q4 25
$-4.5M
$52.5M
Q3 25
$-1.3M
$13.6M
Q2 25
$-11.7M
$13.9M
Q1 25
$-7.5M
$9.2M
Q4 24
$-10.7M
$30.0M
Q3 24
$-3.8M
$13.7M
Q2 24
$-11.8M
$6.7M
Q1 24
$-7.3M
$3.8M
FCF Margin
CYRX
CYRX
NFBK
NFBK
Q4 25
-10.0%
127.1%
Q3 25
-2.9%
34.6%
Q2 25
-25.7%
35.7%
Q1 25
-18.3%
26.3%
Q4 24
-25.8%
81.6%
Q3 24
-9.9%
43.2%
Q2 24
-29.8%
21.1%
Q1 24
-19.5%
12.1%
Capex Intensity
CYRX
CYRX
NFBK
NFBK
Q4 25
12.0%
2.8%
Q3 25
7.8%
0.8%
Q2 25
9.6%
0.6%
Q1 25
7.7%
0.7%
Q4 24
12.6%
3.1%
Q3 24
11.1%
0.7%
Q2 24
9.5%
0.8%
Q1 24
10.7%
1.4%
Cash Conversion
CYRX
CYRX
NFBK
NFBK
Q4 25
Q3 25
1.29×
Q2 25
-0.07×
1.48×
Q1 25
1.20×
Q4 24
2.76×
Q3 24
0.56×
2.14×
Q2 24
1.16×
Q1 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons